Rutgers University New Jersey Medical School Part of Worldwide HIV Vaccine Trial
February 20, 2020
February 20, 2020
NEW BRUNSWICK, New Jersey, Feb. 20 -- Rutgers University issued the following news:
Rutgers New Jersey Medical School (NJMS) Clinical Research Center will be part of a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade.
"We are the only New Jersey site participating in the study, and it's great that we are able to bring this effort to Essex and Hudson counties," says Shobha . . .
Rutgers New Jersey Medical School (NJMS) Clinical Research Center will be part of a worldwide effort to enroll 3,800 HIV negative individuals in the first Phase 3 HIV vaccine efficacy trial conducted in more than a decade.
"We are the only New Jersey site participating in the study, and it's great that we are able to bring this effort to Essex and Hudson counties," says Shobha . . .